AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Using ROSA for Challenging The TKA Standard of Care

RecruitingNAAges 21 Years - 80 YearsAllLondon Health Sciences Centre Research Institute โ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This is a prospective, randomized controlled trial using the cruciate retaining, MC Persona to comparing the conventional TKA to ROSA assisted TKA. Patients will be randomized to one of three study trial arms. 1. Standard of care medial parapetallar approach (Control) 2. ROSA PSA medial parapetallar approach 3. ROSA PSA medial subvastus approach Participants will be followed for 1 year post surgery with a combination of perioperative parameters, imaging, patient reported outcomes, functional outcomes, blood and tissue sampling for inflammatory information and activity levels.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty * Varus knee deformity of 0 to 10 degrees * Sufficient ligamentous function to warrant retention of the posterior cruciate ligament * Between the ages of 21 and 80 inclusive * Patients willing and able to comply with follow-up requirements and self-evaluations * Ability to give informed consent Exclusion Criteria: * Active or prior infection * Medical condition precluding major surgery * Predominantly inflammatory arthropathy * Patellectomy * PCL deficiency * Major coronal plane deformity * Prior trauma to the tibia or femur resulting in malalignment, canal occlusion, or open reduction and internal fixation * Valgus alignment * Neurologic condition limiting mobility * Bone defects requiring augments, cones and/or stemmed implants * Intraoperative findings of insufficient contact between the implant and the bone surface * Body Mass Index of 40 or more
๐Ÿ’Š

What it tests

  • ROSA PSA Parapatellar Approach
  • ROSA PSA Subvastus Approach
๐Ÿ“

Where

1 site
University Hospital
London, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy